Evaluation of equine fetal growth from day 100 of gestation to parturition by ultrasonography.

J Reprod Fertil Suppl

Department of Veterinary Surgical and Radiological Sciences, University of California at Davis, Davis, CA 95616, USA.

Published: July 2011

Transrectal and transabdominal ultrasonography were performed on normal pregnant mares (n=10) at 2 week intervals from day 100 of gestation to parturition to evaluate fetal growth. Several fetal anatomical regions (head, eye, aorta, abdomen, rib, gonad, kidney and femur) were imaged and measured using standardized scan plans. The results of these analyses indicate that all of the biometric parameters correlate strongly with the day of gestation. Growth charts were developed, which demonstrate that the following variables have linear relationships with the day of gestation on which they were measured: aortic systolic diameter, biparietal diameter, approximate eye volume, femur length and kidney cross-sectional area. The linear regression equation across days was developed for aortic, systolic and biparietal diameter, approximate eye volume, femur length and kidney cross-sectional area, thus allowing assessment of normal equine fetal development after day 100 of gestation. This non-invasive method can be used to estimate fetal age if mating or ovulation dates are unknown, provided the fetus is developing normally. The use of transrectal and transabdominal ultrasonography, as well as different probe frequencies (5.0 or 3.5 MHz), to measure different biometric parameters during gestation is reported.

Download full-text PDF

Source

Publication Analysis

Top Keywords

day 100
12
100 gestation
12
equine fetal
8
fetal growth
8
gestation parturition
8
transrectal transabdominal
8
transabdominal ultrasonography
8
biometric parameters
8
day gestation
8
aortic systolic
8

Similar Publications

Methane production from anaerobic pre-treatment of municipal wastewater combined with olive mill wastewater: A demonstration study.

Water Sci Technol

January 2025

The Institute of Applied Research, The Galilee Society, Shefa-Amr 2020000, Israel; Agrobics Ltd, Shefa-Amr 2020000, Israel; Prof. Ephraim Katzir Department of Biotechnology Engineering, Braude College of Engineering, Karmiel 2161002, Israel.

The advanced anaerobic technology (AAT), developed based on an immobilized high-rate anaerobic reactor, was applied as a pretreatment of municipal wastewater (WW) at Karmiel's treatment plant in Israel. The demonstration-scale AAT (21 m) system was operated at a flow rate of 100 mday municipal WW mixed with olive mill wastewater (OMW) (0.5 mday) to simulate the scenario of illegal discharge of agro-industrial WW.

View Article and Find Full Text PDF

Background: Nirmatrelvir/ritonavir is licensed for the treatment of mild-to-moderate coronavirus disease (COVID-19) in patients at an increased risk of progression to severe disease. However, data on the real-world plasma exposure to nirmatrelvir/ritonavir remain limited, particularly in Chinese patients. This study aimed to assess the nirmatrelvir/ritonavir trough concentration (Ctrough) and identify its critical factors in hospitalized Chinese patients treated with nirmatrelvir/ritonavir 300 mg/100 mg twice daily over a 5-day course.

View Article and Find Full Text PDF

This project investigated the generation and characterization of post-service food waste at Georgia Gwinnett College dining hall from Spring 2022 to Spring 2023. In Spring 2022, for three weeks, twice a week, a total of 115.08 kg of post-service food waste was collected by cafeteria workers.

View Article and Find Full Text PDF

Aim And Background: A combination of terlipressin and albumin is the standard of care for patients with hepatorenal syndrome-acute kidney injury (HRS-AKI). The study aimed to compare the venous congestion using lung ultrasound score (LUS) and radiographic assessment of lung edema (RALE) scores among terlipressin responders and nonresponders and survivors and non-survivors.

Materials And Methods: In this single-center, prospective, observational study, we included adult patients with HRS-AKI who had received terlipressin and albumin from 28th April 2022 to 16th October 2022.

View Article and Find Full Text PDF

A 53-year-old woman undergoing combination therapy with epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) inhibitors for advanced lung cancer with brain metastases developed pustules and punctate purpura on both lower extremities. Histopathological examination revealed neutrophilic infiltration around the hair follicles and erythrocyte extravasation in the perivascular regions near the hair roots, leading to a diagnosis of purpuric papulopustular eruptions. The rash improved with oral doxycycline (100 mg/day) and topical corticosteroids.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!